While the prevalence of migraine amongst Americans has remained fairly constant over the last fifteen years, our knowledge of migraine and the treatment options have grown significantly. What have we learned most recently about migraine and about vascular risks associated with migraine? Dr. Stephen Silberstein, professor of neurology and director of the Jefferson Headache Center at Thomas Jefferson University, joins host Dr. Anthony Alessi to discuss the latest research on treating migraine and the vascular risks associated with migraine.
